在医疗保险受益者的体外心肺复苏
Jeremiah W Awori Hayanga1, Hakam Rajjoub1, J Hunter Mehaffey1
1Department of Cardiovascular and Thoracic Surgery, West Virginia University Heart and Vascular Institute, Morgantown, WV.
JTCVS open
|December 31, 2025
概括
老年医疗保险患者的体外心肺复苏 (ECPR) 显示了高的住院死亡率,随着年龄的增长而增加. 出院后的生存率约为90%,但长期结果仍然是这个脆弱人群的担忧.
科学领域:
- 心脏病学 心脏病学
- 关键护理医学 关键护理医学
- 老年病的医生 老年病的医生
背景情况:
- 由于高死亡率和资源密集度,老年患者使用体外心肺复苏 (ECPR) 仍在争论中.
- 在老年人群中评估ECPR结果对于明智的临床决策至关重要.
研究的目的:
- 评估医疗保险受益者在心脏骤停后接受ECPR治疗的结果.
- 分析年龄和并发症对老年人ECPR存活率的影响.
主要方法:
- 利用医疗保险住院患者分析档案 (2018-2023) 识别接受静脉外体膜氧化 (VA-ECMO) 的患者.
- 在入院期间心脏骤停的受益者中定义了ECPR队列 (n=1174).
- 使用ICD-10代码和验证的指标评估并发症和脆弱性.
主要成果:
- 在ECPR队列的住院死亡率为63.8%.
- 随着年龄的增长,五年死亡率增加了69.8% (<70),78.0% (71-80),86.8% (>80).
- 取决于是否幸存下来,五年死亡率约为10%.
结论:
- 医疗保险接受者的ECPR与大量的住院死亡率有关,特别是在老年人中.
- 年龄是影响ECPR后死亡风险的重要因素.
- 这些发现提供了现实世界的数据,以指导老年心脏骤停患者复杂的复苏决策.
相关概念视频
Cardiopulmonary Resuscitation I: Adult
531
Cardiopulmonary resuscitation, or CPR, is a life-saving emergency procedure performed when a person's heart has stopped beating or they are no longer breathing. The foundation of CPR is Basic Life Support (BLS), which focuses on the early recognition of cardiac arrest, the immediate start of high-quality chest compressions, and the timely use of an automated external defibrillator (AED).Assessing Responsiveness and Checking the Carotid PulseWhen approaching an unresponsive person, first ensure...
531
Cardiopulmonary Resuscitation III: AED Use
481
Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
481
Cardiopulmonary Resuscitation IV: Pharmacological Management
570
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
570
Cardiopulmonary Resuscitation II: ACLS Airway Management
481
Airway management is a key skill in emergency and critical care settings, as maintaining a clear airway is essential for adequate oxygenation and ventilation.Head Tilt-Chin Lift TechniqueThe head tilt-chin lift maneuver is an essential technique primarily used in patients without suspected cervical spine injuries. To perform this maneuver, one hand is placed on the patient’s forehead, and gentle pressure is applied backward to tilt the head. The fingertips of the other hand are positioned...
481
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
162
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
162
Cardiomyopathy II: Dilated Cardiomyopathy
431
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
431


